This is a preview of subscription content, log in via an institution to check access.
References and Further Reading
Abraham, S. C., Montgomery, E. A., Giardiello, F. M., & Wu, T. T. (2001). Frequent beta-catenin mutations in juvenile nasopharyngeal angiofibromas. The American Journal of Pathology, 158, 1073–1078.
Boghani, Z., Husain, Q., Kanumuri, V. V., Khan, M. N., Sangvhi, S., Liu, J. K., & Eloy, J. A. (2013). Juvenile nasopharyngeal angiofibroma: A systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases. The Laryngoscope, 123, 859–869.
Douglas, R., & Wormald, P. J. (2006). Endoscopic surgery for juvenile nasopharyngeal angiofibroma: Where are the limits? Current Opinion in Otolaryngology & Head and Neck Surgery, 14, 1–5.
Ferouz, A. S., Mohr, R. M., & Paul, P. (1995). Juvenile nasopharyngeal angiofibroma and familial adenomatous polyposis: An association? Otolaryngology and Head and Neck Surgery, 113, 435–439.
Gates, G. A., Rice, D. H., Koopmann, C. F., Jr., & Schuller, D. E. (1992). Flutamide-induced regression of angiofibroma. The Laryngoscope, 102, 641–644.
Hwang, H. C., Mills, S. E., Patterson, K., et al. (1998). Expression of androgen receptors in nasopharyngeal angiofibroma: An immunohistochemical study of 24 cases. Modern Pathology, 11, 1122–1126.
Klockars, T., Renkonen, S., Leivo, I., Hagström, J., & Mäkitie, A. A. (2010). Juvenile nasopharyngeal angiofibroma: No evidence for inheritance or association with familial adenomatous polyposis. Familial Cancer, 9, 401–403.
Leong, S. C. (2013). A systematic review of surgical outcomes for advanced juvenile nasopharyngeal angiofibroma with intracranial involvement. The Laryngoscope, 123, 1125–1131.
Makek, M. S., Andrews, J. C., & Fisch, U. (1989). Malignant transformation of a nasopharyngeal angiofibroma. The Laryngoscope, 99, 1088–1092.
Montag, A. G., Tretiakova, M., & Richardson, M. (2006). Steroid hormone receptor expression in nasopharyngeal angiofibromas. Consistent expression of estrogen receptor beta. American Journal of Clinical Pathology, 125, 832–837.
Renkonen, S., Heikkilä, P., Haglund, C., Mäkitie, A. A., & Hagström, J. (2013). Tenascin-C, GLUT-1, and syndecan-2 expression in juvenile nasopharyngeal angiofibroma: Correlations to vessel density and tumor stage. Head & Neck, 35, 1036–1042.
Wang, J. J., Sun, X. C., Hu, L., Liu, Z. F., Yu, H. P., Li, H., Wang, S. Y., & Wang, D. H. (2013). Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: Tissue microarray analysis and association with prognostic significance. Head & Neck, 35, 1719–1725.
Yi, Z., Fang, Z., Lin, G., Lin, C., Xiao, W., Li, Z., Cheng, J., & Zhou, A. (2013). Nasopharyngeal angiofibroma: A concise classification system and appropriate treatment options. American Journal of Otolaryngology, 34, 133–141.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this entry
Cite this entry
Franchi, A. (2019). Angiofibroma, Nasopharyngeal. In: van Krieken, J. (eds) Encyclopedia of Pathology. Encyclopedia of Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-28845-1_5344-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-28845-1_5344-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28845-1
Online ISBN: 978-3-319-28845-1
eBook Packages: Springer Reference MedicineReference Module Medicine